We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVHI icon
2676
KVH Industries
KVHI
$181M
$223K ﹤0.01%
18,678
+430
+2% +$4.69K
PZN
2677
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$223K ﹤0.01%
20,464
+85
+0.4% +$868
BSF
2678
DELISTED
Bear State Financial, Inc.
BSF
$223K ﹤0.01%
21,755
+255
+1% +$2.47K
KURA icon
2679
Kura Oncology
KURA
$800M
$222K ﹤0.01%
14,845
+746
+5% +$7K
CCXI
2680
DELISTED
ChemoCentryx, Inc.
CCXI
$222K ﹤0.01%
29,953
+705
+2% +$5.86K
PFBI
2681
DELISTED
Premier Financial Bancorp
PFBI
$221K ﹤0.01%
12,676
+312
+3% +$4.94K
CADE
2682
DELISTED
Cadence Bancorporation
CADE
$221K ﹤0.01%
9,657
+190
+2% +$4.15K
LCUT icon
2683
Lifetime Brands
LCUT
$191M
$220K ﹤0.01%
12,035
-200
-2% -$3.59K
VCYT icon
2684
Veracyte
VCYT
$3.7B
$220K ﹤0.01%
25,119
+370
+1% +$3.01K
HALL
2685
DELISTED
Hallmark Financial Services, Inc.
HALL
$219K ﹤0.01%
1,887
-32
-2% -$3.55K
PDSB icon
2686
PDS Biotechnology
PDSB
$38.4M
$218K ﹤0.01%
1,014
+16
+2% +$3.31K
TNAV
2687
DELISTED
Telenav Inc.
TNAV
$218K ﹤0.01%
34,366
-105
-0.3% -$730
MOBL
2688
DELISTED
MobileIron, Inc.
MOBL
$218K ﹤0.01%
58,797
+915
+2% +$4.11K
DLTH icon
2689
Duluth Holdings
DLTH
$155M
$217K ﹤0.01%
10,673
+120
+1% +$2.32K
ULH icon
2690
Universal Logistics Holdings
ULH
$353M
$217K ﹤0.01%
10,589
+75
+0.7% +$1.2K
AFH
2691
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$217K ﹤0.01%
11,474
-263
-2% -$4.26K
PVLA
2692
Palvella Therapeutics
PVLA
$1.99B
$216K ﹤0.01%
468
+14
+3% +$5.98K
SFS
2693
DELISTED
Smart & Final Stores, Inc.
SFS
$216K ﹤0.01%
27,509
+150
+0.5% +$1.15K
CEMP
2694
DELISTED
Cempra, Inc.
CEMP
$216K ﹤0.01%
66,571
+985
+2% +$3.48K
INBK icon
2695
First Internet Bancorp
INBK
$257M
$215K ﹤0.01%
+6,644
New +$202K
LCTX icon
2696
Lineage Cell Therapeutics
LCTX
$269M
$215K ﹤0.01%
86,641
+686
+0.8% +$1.7K
NPTN
2697
DELISTED
NEOPHOTONICS CORP
NPTN
$215K ﹤0.01%
38,654
+150
+0.4% +$1.01K
CWCO icon
2698
Consolidated Water Co
CWCO
$467M
$214K ﹤0.01%
16,687
+110
+0.7% +$1.38K
WINS
2699
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
$213K ﹤0.01%
1,012
MBTF
2700
DELISTED
MBT Financial Corporation
MBTF
$213K ﹤0.01%
19,470
+130
+0.7% +$1.29K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.